Effect of troglitazone on radiation sensitivity in cervix cancer cells

PURPOSE: Troglitazone (TRO) is a peroxisome proliferator-activated receptor γ (PPARγ) agonist. TRO has antiproliferative activity on many kinds of cancer cells via G1 arrest. TRO also increases Cu(2+)/Zn(2+)-superoxide dismutase (CuZnSOD) and catalase. Cell cycle, and SOD and catalase may affect on...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: An, Zhengzhe, Liu, Xianguang, Song, Hyejin, Choi, Chihwan, Kim, Won-Dong, Yu, Jae-Ran, Park, Woo-Yoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Society for Radiation Oncology 2012
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429892/
https://ncbi.nlm.nih.gov/pubmed/22984686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2012.30.2.78
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia